Tempest Therapeutics, Inc. — Director's Dealing 2015

Apr 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2015-04-08

Reporting Person: TZIANABOS ARTHUR (President and CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-08	Common Stock	P	175	$28.04	Acquired	175	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000	Indirect